Zydus Lifesciences Limited has informed the Exchange about change in Management
ZYDUSLIFE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Zydus Lifesciences announced the appointment of Ms. Swati Dalal (DIN: 01513751) as Additional Director and Managing Director of its wholly owned subsidiary, Zydus Healthcare Limited (ZHL), effective June 16, 2025, for a 5-year term. She will also form part of the Senior Management of Zydus Lifesciences. Ms. Dalal brings over 30 years of commercial leadership experience, most recently as Managing Director of Abbott India Ltd, with prior senior roles across Abbott Nutrition, Abbott Primary Care, and commercial functions. She holds a pharmacy degree and an MBA from JBIMS Mumbai. She is not related to any existing directors of the Company or ZHL.
This is a senior leadership addition at the subsidiary level, bringing experienced external talent from a major pharma peer (Abbott). For shareholders, it signals continued investment in leadership depth, but is unlikely to cause immediate stock price movement as the appointment is at a subsidiary and is a new addition rather than a replacement of a key exiting leader.